SAFE taxation in Israel: what the Tax Authority's guidance actually says

What a SAFE is, and why pre-seed runs on it

SAFE - Simple Agreement for Future Equity - is the format most pre-seed and early-seed rounds close on today, in Israel and worldwide. The idea is genuinely simple: the investor wires the money now but receives no shares now. Instead they receive a contractual commitment to receive shares in the next financing round - at a better price. How much better? That is set by the instrument's two famous mechanisms:

• Discount: a fixed discount on the share price of the next round. A 20% discount means the early investor buys the same share at 80% of what the round's investors pay - their compensation for entering when there was mostly a deck and courage.
• Cap (valuation cap): a ceiling on the valuation used for conversion. If the company takes off and raises at a $30M valuation but the cap in the agreement is $8M - the early investor converts as if the valuation were $8M, receiving far more shares for the same money. Where both a discount and a cap exist, the investor usually gets the better of the two.
• Post-money SAFE: today's standard variant. The cap is phrased on a post-money basis, so the investor knows at signing what minimum percentage of the company they will receive - and you know exactly how much dilution you took. Fewer surprises, more spreadsheet.

And why does everyone use it? Because a SAFE solves the most annoying problem of early fundraising - the valuation argument over a company with almost nothing to measure. No valuation now, no interest, no maturity date, no collateral: it is not a loan to repay but an entry ticket to the next round. The document is short and standardized, legal costs are low, and signing can happen in days instead of months.

One more important stop before we continue: a SAFE is an investment in a company. If you are still an osek murshe or "an idea with a GitHub repo", there is nothing to sign on - first incorporate an Israeli company, then raise.

The problem there used to be: loan or equity?

Now to the part you are really here for. For years an open tax question hovered over the SAFE: how does the Tax Authority classify this instrument? On one hand it has a clearly equity character. On the other, one could argue differently: the money is given today, the shares arrive only in the future, and the investor receives an "extra" in the form of a discount. Sounds a bit like a loan whose benefit is interest, no?

And if it is a loan - the outcome hurts everyone:

• For the investor: the discount is classified as interest or income - and taxed already at conversion. Tax on a gain that exists only on paper, before the investor has seen a single shekel in cash.
• For the company: a duty to withhold tax at source on that "interest" - bureaucracy inside a transaction that has no cash flow to withhold from, and real exposure for the company if it failed to withhold.
• For the round itself: investors - especially foreign ones - dislike tax uncertainty. Indemnity clauses, opinions, conditions and delays: everything the SAFE was meant to save would come back in through the side door.

Note the nuance: the problem was never that the tax was "too high" - it was that it could arrive too early (at conversion instead of at sale), with no cash to pay it from, and with uncertainty that cannot be priced into a deal. Exactly the three problems the Tax Authority's guidance came to solve.

The updated guidance - all the conditions, in one table

On May 16, 2023, the Tax Authority first published professional guidance that brought order, and on January 29, 2025, an updated and improved version was published. The updated guidance applies to SAFE transactions signed from January 1, 2025 through December 31, 2026 (or until new guidance is published - the earlier of the two), meaning it is in full force as of August 2026. For earlier deals, its principles can inform interpretation - the economic logic is identical.

The guidance's bottom line is generous and clear: a SAFE that meets the conditions is classified as an advance on account of shares - an equity investment in every respect. The practical meaning is threefold: the conversion into shares is not a tax event, the company has no withholding duty, and the only tax the investor will meet is capital-gains tax on a future sale of the shares. These are the core conditions:

Two points from the table worth stressing. One - raising the cap to $20 million per investor is a real upgrade over the original guidance: very large checks now fit inside the certainty zone, no acrobatics needed. Two - the discount structure: the guidance dislikes a discount that "climbs with time" continuously, because such a discount behaves exactly like interest. What is allowed: up to three discount steps over up to three years. If your investor proposes an especially creative discount schedule - that is precisely the clause to check before signing, not after.

What it means in practice - for the company and the investor

On your side, the company: the money is booked as equity - an advance on account of shares - not as a financial liability that demands revaluations and complicates the balance sheet. No withholding duty at conversion, no interest reporting, and no expense deduction for the SAFE (that is part of the deal's terms - you received equity, you did not take a loan). The result: a clean, readable balance sheet - which matters not only vis-a-vis the Tax Authority but also in the due diligence of your next round.

On the investor's side: quiet until the exit. The conversion is not a tax event; tax arrives only on an actual sale of the shares, as a capital gain - 25%, or 30% for a substantial shareholder, plus the 3% surtax where taxable income crosses 721,560 ILS. In between, the sale restriction applies: no selling before 12 months from the SAFE's signing or 9 months from the share issuance (the later relevant). For a serious pre-seed investor this is a theoretical restriction - nobody sells seed shares after half a year - but it must be known, documented and respected.

And if the conditions are breached? No case file opens - you simply exit the certainty zone. The guidance will not apply automatically, and the classification will follow the transaction's substance: interest or linkage put the loan question back on the table, and a discount that behaves like interest - likewise. In large or borderline cases, an advance tax ruling can be requested from the Tax Authority. The simple principle: the check is done before signing. Fixing a signed agreement is expensive; fixing a draft is an email.

Our pre-signing checklist:

• The document is clean of interest, linkage and collateral - including in appendices, addenda and side letters. Sometimes the "linkage" hides in innocent-looking wording.
• The discount is fixed or lawfully stepped - up to 3 steps over up to 3 years, not a formula that crawls with time.
• Each single investor's amount is within the guidance's cap.
• The conversion trigger is defined as a qualified financing round, and the sale restrictions (12/9 months) are known to all parties.
• The SAFE is not tradable and not freely transferable - the transferability clause is drafted accordingly.
• The cap table is updated and includes all previous SAFEs - on that surprise, the next chapter.

SAFEs in the field: foreign investors, stacking, and the road to a priced round

A foreign investor. Here the guidance is worth gold. Withholding duties toward a foreign investor used to be a real operational headache - and thanks to the equity classification, none arises when the conditions hold. What remains to coordinate: the investor's reporting in their own country of residence is their business, but it will affect the documents they ask of you - so do not be surprised by requests for confirmations. And if the American investor announces that "a condition of the investment is a Delaware company"? Stop for a moment: the guidance applies to a private Israeli-resident company, and a flip changes your entire tax picture - not just the SAFE's. Read the Delaware guide before promising anything by email.

A stack of SAFEs. A SAFE almost never comes alone: you sign one in October, another in February, a third in June - each with its own cap and discount. Each signing feels cheap on its own, but at the priced round they all convert together, and the cumulative dilution is the moment founders discover how much of the company they actually hold. Our rule: after every signing, update a full cap table under an "everything converts" scenario, and check that the equity split between the founders still makes sense - a matter that should have been settled earlier, in the founders' agreement.

When do you move to a priced round? When the amounts grow and investors want a price, rights and a board seat; when the SAFE stack already creates dilution loads that are hard to compute in your head; or when you finally have numbers that can be priced. The SAFE is an excellent bridge - it is just not supposed to be the house.

And if your investors are Israeli - get to know the Angels' Law: a tax credit for an individual investor of 25%-30% of the amount invested in a qualifying early-stage company (in practice up to roughly 33% including surtax). Note the benefit is built on an investment in shares, so combining it with a SAFE requires early timing planning.

Where do we come in? We go over the SAFE draft through tax and accounting glasses (the legal side stays with the lawyers), flag every clause that endangers the equity classification, align the books and the annual report - and send you back to building the product. Send us the draft on WhatsApp - a week before signing beats a day after.